Culturally centered MED. Assisted treatment OUD implementation for primary care and addiction treatment programs serving AI/an (CTN-0096). 03/01/2022 - 11/01/2024. DSC6. 75N95023F00001 (TO5).
Ended Awarded Last action
- Contract number
- 75N95023F00001
- Awardee
-
The Emmes Company, LLC UEI NBQCBJ6FXBU4
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $499,837
Award facts
- Contract value 100% obligated
- $499,837.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Rockville, MD 20850, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Change Order | $0 | |
| Original award | $499,837 |
About this award
The National Institute on Drug Abuse (NIDA) awarded a $499,837.00 Delivery Order contract to The Emmes Company LLC for the implementation of Culturally Centered Medication-Assisted Treatment for Opioid Use Disorder (OUD) in primary care and addiction treatment programs serving American Indian/Alaska Native (AI/AN) populations. The contract runs from March 1, 2022, to November 1, 2024, with a total completion date of March 31, 2025. This task order was issued under NIDA's $31 million Indefinite Delivery Vehicle for data, statistics, and clinical trial support services. The Emmes Company LLC is a global clinical research organization that has secured numerous prime and subcontracts from various NIH institutes to provide comprehensive research support services, including biostatistical analysis, data management, and clinical trial coordination. This task order is not set aside for any specific business type.
Quick answers
Who was awarded contract 75N95023F00001?
75N95023F00001 was awarded to The Emmes Company, LLC by National Institute on Drug Abuse (National Institutes of Health) on March 1, 2023.
How much is contract 75N95023F00001 worth?
The government has obligated $499,837 on 75N95023F00001.
Is contract 75N95023F00001 an order under another contract?
Yes. 75N95023F00001 is a delivery order under 75N95022D00017, an indefinite delivery contract.
Was contract 75N95023F00001 competed?
The extent of competition for 75N95023F00001 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award